Call us: +202 22 905 906
E-Mail: mail@alpha-pharmaceuticals.com
You are here
National Institutes of Health (NIH)
Findings could pave the way for more personalized treatments for cardiovascular disease.
An observational study of more than 6,500 adults is one of the most detailed in the U.S.
New NIH-funded data show lower use of most substances continues following the COVID-19 pandemic.
Many differences appeared to exist prior to any substance use, pointing to the role brain structure may play in substance use risk, NIH-supported study suggests.
NIH-funded study shows benefits of pain coping skills training in population with limited pain treatment options.
NIH-funded mouse study provides roadmap for how aging may alter brain cell genetic activity.
New antibodies could lead to next generation of interventions against malaria.
ME/CFS is a complex, serious, and chronic condition that often occurs following an infection.
NIH-funded study finds progression of eye growth returns to normal in older teens, with no loss of treatment benefit.